BCM
CVS icon

Brookstone Capital Management’s CVS Health CVS Stock Holding History

Brookstone Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Sell
29,402
-966
-3% -$86.2K 0.03% 419
2026
Q1 		$2.18M Sell
30,368
-5,746
-16% -$443K 0.02% 448
2025
Q4 		$2.87M Buy
36,114
+4,282
+13% +$338K 0.03% 386
2025
Q3 		$2.4M Sell
31,832
-56,464
-64% -$3.87M 0.03% 412
2025
Q2 		$6.09M Buy
88,296
+15,401
+21% +$1.01M 0.08% 256
2025
Q1 		$4.94M Buy
72,895
+3,475
+5% +$208K 0.07% 254
2024
Q4 		$3.12M Buy
69,420
+6,831
+11% +$383K 0.05% 316
2024
Q3 		$3.94M Buy
62,589
+2,764
+5% +$161K 0.06% 279
2024
Q2 		$3.69M Sell
59,825
-5,332
-8% -$334K 0.06% 278
2024
Q1 		$5.2M Buy
65,157
+2,054
+3% +$157K 0.09% 214
2023
Q4 		$4.98M Buy
63,103
+2,988
+5% +$213K 0.1% 206
2023
Q3 		$4.24M Buy
60,115
+9,303
+18% +$659K 0.09% 205
2023
Q2 		$3.51M Sell
50,812
-680
-1% -$48.4K 0.07% 238
2023
Q1 		$3.9M Buy
51,492
+21,535
+72% +$1.81M 0.08% 228
2022
Q4 		$2.74M Sell
29,957
-1,131
-4% -$109K 0.06% 255
2022
Q3 		$2.73M Buy
31,088
+3,192
+11% +$316K 0.06% 234
2022
Q2 		$2.63M Sell
27,896
-7,994
-22% -$780K 0.06% 252
2022
Q1 		$3.75M Sell
35,890
-4,853
-12% -$510K 0.07% 221
2021
Q4 		$4.25M Buy
40,743
+11,940
+41% +$1.1M 0.07% 194
2021
Q3 		$2.4M Buy
28,803
+61
+0.2% +$5.11K 0.04% 244
2021
Q2 		$2.35M Buy
28,742
+6,947
+32% +$569K 0.04% 244
2021
Q1 		$1.64M Sell
21,795
-42,168
-66% -$3.07M 0.06% 202
2020
Q4 		$4.37M Buy
63,963
+5,620
+10% +$366K 0.17% 105
2020
Q3 		$3.41M Buy
58,343
+45,037
+338% +$2.8M 0.16% 99
2020
Q2 		$864K Sell
13,306
-1,346
-9% -$84.8K 0.05% 180
2020
Q1 		$869K Buy
14,652
+50
+0.3% +$3.34K 0.05% 172
2019
Q4 		$1.08M Sell
14,602
-159
-1% -$11.2K 0.06% 160
2019
Q3 		$931K Buy
14,761
+8,708
+144% +$516K 0.05% 203
2019
Q2 		$330K Buy
6,053
+825
+16% +$44.4K 0.02% 353
2019
Q1 		$282K Buy
5,228
+1,501
+40% +$92.6K 0.02% 338
2018
Q4 		$244K Buy
3,727
+74
+2% +$5.52K 0.02% 256
2018
Q3 		$288K Buy
+3,653
New +$261K 0.02% 346
2017
Q4 		– Sell
-2,731
Closed -$222K – 319
2017
Q3 		$222K Sell
2,731
-422
-13% -$33.4K 0.02% 299
2017
Q2 		$254K Buy
3,153
+55
+2% +$4.34K 0.02% 271
2017
Q1 		$243K Buy
+3,098
New +$247K 0.02% 218
2015
Q4 		– Sell
-2,060
Closed -$199K – 304
2015
Q3 		$199K Buy
2,060
+472
+30% +$49.6K 0.04% 174
2015
Q2 		$167K Sell
1,588
-350
-18% -$35.8K 0.02% 254
2015
Q1 		$200K Buy
+1,938
New +$196K 0.03% 181

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Brookstone Capital Management's CVS Position: Q2 2026 in Review

Brookstone Capital Management reduced its CVS Health (CVS) stake by 3.2% in Q2 2026, selling an estimated $86.2K and leaving 29,402 shares worth $3.04M. The position accounts for 0.03% of the portfolio, ranked #419.

Brookstone Capital Management first reported a position in CVS in Q1 2015 and has held it in 38 quarters since. The position peaked at $6.09M in Q2 2025. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Brookstone Capital Management held 29,402 shares of CVS Health worth $3.04M as of Q2 2026.
  • Brookstone Capital Management sold 966 CVS Health shares in Q2 2026, an estimated $86.2K.
  • CVS Health made up 0.03% of Brookstone Capital Management's portfolio in Q2 2026, its #419 holding.
  • Brookstone Capital Management first reported a position in CVS Health in Q1 2015 and has held it in 38 quarters since.
  • Brookstone Capital Management's CVS Health position peaked at $6.09M in Q2 2025.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.